Transforming Cancer Treatment: Integrative Strategies Targeting the Tumor Microenvironment through Biological...

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• Cancer is increasingly understood as a disease driven by its microenvironment, not just genetic mutations.
• The tumor microenvironment (TME) is a dynamic ecosystem involving malignant cells, immune cells, stromal elements, and vasculature.
• Interactions within the TME regulate tumor initiation, progression, immune evasion, and metastasis.

Purpose of the Study:

• To comprehensively review the cellular and acellular architecture of the TME.
• To emphasize the spatial organization, metabolic reprogramming, mechanical properties, and immunological regulation of the TME.
• To discuss current and emerging therapeutic strategies targeting the TME.

Main Methods:

• Review of existing literature on tumor microenvironment components and functions.
• Analysis of key TME features like hypoxia, oxidative stress, metabolic competition, ECM remodeling, and vascular abnormalities.
• Examination of therapeutic approaches including immunotherapy, cell therapies, and combination regimens.

Main Results:

• The TME establishes immunosuppressive and therapy-resistant niches promoting tumor growth and spread.
• Hypoxia, metabolic competition, and ECM remodeling are critical TME features.
• Therapeutic strategies are evolving to exploit TME vulnerabilities, with AI aiding target identification.

Conclusions:

• Understanding TME co-evolution is vital for developing next-generation cancer therapies.
• Integrating spatial biology, metabolomics, and mechanobiology will enable precise TME modulation.
• Overcoming challenges like tumor heterogeneity and resistance is key for durable clinical benefit.